Cross‐sectional and Mendelian randomization study of fibroblast growth factor 19 reveals causal associations with metabolic diseases

Documenti analoghi

• Mendelian‐randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures
  di: Xiong Pei, et al.
  Pubblicazione: (2024)
• Performance of MAST, FAST, and MEFIB in predicting metabolic dysfunction‐associated steatohepatitis
  di: Shi Qi, et al.
  Pubblicazione: (2024)
• Nonlesional ileal transcriptome in Crohn's disease reveals alterations in immune response and metabolic pathway
  di: Ho‐Su Lee, et al.
  Pubblicazione: (2024)
• LIVERSTAT for risk stratification for patients with metabolic dysfunction‐associated fatty liver disease
  di: Yong Wen Leow, et al.
  Pubblicazione: (2024)
• Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease
  di: Yi‐Ting Chen, et al.
  Pubblicazione: (2024)